Percentage of Her2 positive cells in immunohistochemistry-equivocal (2+) invasive breast cancer and its significance as a predictive value for the amplification status

被引：0
|
作者：
Marras, V. [1 ]
Satta, G. [1 ]
Fedeli, M. A. [1 ]
Trombetta, M. [1 ]
Lako, K. [1 ]
Meloni, M. [1 ]
Fara, A. M. [1 ]
Camboni, A. C. [1 ]
Doneddu, V. [1 ]
Manca, A. [1 ]
Tanda, F. [1 ]
机构：
[1] AOU Sassari, UO Anat Patol, Sassari, Italy
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-034
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [41] Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive for false-negative immunohistochemistry?
    Barrett, Ciara
    Magee, Hilary
    O'Toole, Denise
    Daly, Sinead
    Jeffers, Michael
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (06) : 690 - 693
  • [42] Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by Immunohistochemistry
    Tsai, Yi-Fang
    Hsu, Chih-Yi
    Chiu, Yun-Ning
    Huang, Chi-Cheng
    Chou, Shih-Hsiang
    Lin, Yen-Shu
    Chao, Ta-Chung
    Liu, Chun-Yu
    Chiu, Jen-Hwey
    Tseng, Ling-Ming
    BREAST CANCER-TARGETS AND THERAPY, 2025, 17 : 253 - 263
  • [43] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 44A - 44A
  • [44] Impact of the Change of the Criteria for HER2 Immunohistochemistry Interpretation on HER2 Status in Breast Cancer
    Harada, Shuko
    Shen, Dejun
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 44A - 44A
  • [45] Standardized Assessment of the HER2 Status in Breast Cancer by Immunohistochemistry
    Hicks, David G.
    LABMEDICINE, 2011, 42 (08): : 459 - 467
  • [46] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
  • [47] HER2 Gene Amplification in ER-positive HER2 Immunohistochemistry 0 or 1+Breast Cancer With Early Recurrence
    Yamashita, Hiroko
    Ishida, Naoko
    Hatanaka, Yutaka
    Hagio, Kanako
    Oshino, Tomohiro
    Takeshita, Takashi
    Kanno-Okada, Hiromi
    Shimizu, Ai
    Hatanaka, Kanako C.
    Matsuno, Yoshihiro
    ANTICANCER RESEARCH, 2020, 40 (02) : 645 - 652
  • [48] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [49] HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression
    Seo, A. -N.
    Jeong, J. -Y.
    Lee, S. -J.
    Choe, G. -Y.
    Kwak, Y. -J.
    Kim, W. -H.
    Lee, H. -S.
    VIRCHOWS ARCHIV, 2014, 465 : S223 - S223
  • [50] HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
    Seo, An Na
    Kwak, Yoonjin
    Kim, Duck-Woo
    Kang, Sung-Bum
    Choe, Gheeyoung
    Kim, Woo Ho
    Lee, Hye Seung
    PLOS ONE, 2014, 9 (05):
12345